Today: 1 July 2026
OneStream stock jumps 20% after report says Hg Capital in advanced takeover talks
6 January 2026
1 min read

OneStream stock jumps 20% after report says Hg Capital in advanced takeover talks

New York, Jan 6, 2026, 11:02 (EST) — Regular session

  • OneStream shares rose more than 20% after a report said buyout firm Hg Capital is in advanced talks to acquire the company.
  • The move revives take-private speculation less than two years after OneStream’s IPO.
  • Investors are watching for confirmation and terms, with earnings expected in February.

Shares of OneStream Inc (OS) jumped on Tuesday after Bloomberg News reported buyout firm Hg Capital is in advanced talks to acquire the Nasdaq-listed financial software maker, citing people familiar with the matter. The stock was up about 21% at $22.32 in morning trade, compared with Monday’s close of $18.39, after earlier touching $24.00. Hg and OneStream did not immediately respond to a Reuters request for comment; the company’s market value stands at about $4.5 billion and its shares have fallen about 35% over the past year.

A take-private deal — where a buyer buys out public shareholders and delists the company — would mark a swift turn for OneStream, which went public in July 2024 at $20 a share, a filing showed. Such deals can appeal when public-market valuations lag what buyers think the underlying business can deliver.

Reuters reported in November that OneStream was working with JPMorgan on strategic options, including a possible sale, and that private equity firms such as Blackstone and Hg were among those studying potential bids. OneStream sells corporate performance management software and competes with larger players including Oracle, SAP and Workday, Reuters said.

Bloomberg said a deal could be announced as soon as the coming days, though timing could change and the talks could still end without an agreement. No financial terms were disclosed in the report.

But takeover talks often break down over price, financing or due diligence, and a lack of confirmation can leave shares exposed to a fast reversal if momentum fades. Any bidder would also need to navigate shareholder expectations after Tuesday’s sharp move.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Kymera Therapeutics (KYMR) up 51% YTD as atopic dermatitis drug hits milestones
    July 1, 2026, 2:57 PM EDT. Kymera Therapeutics (KYMR) is up nearly 51% this year, way ahead of the sector's 6.4%. The stock's gain is tied to progress on KT-621, an oral STAT6 degrader for atopic dermatitis and asthma. Kymera wrapped phase IIb enrollment in the BROADEN2 AD trial six months early, aiming to have the pivotal readout by late 2026. Earlier, phase Ib data showed strong STAT6 knockdown and safety. The FDA put KT-621 on Fast Track for moderate-to-severe AD and eosinophilic asthma. Separately, trials for KT-485, in partnership with Sanofi, led to a $20 million milestone, and Kymera is still developing KT-579. Its alliances with Sanofi and Gilead are part of the company's long-term plans.
Hyperscale Data (GPUS) stock jumps 20% in premarket as insider buying keeps spotlight on the microcap
Previous Story

Hyperscale Data (GPUS) stock jumps 20% in premarket as insider buying keeps spotlight on the microcap

SpaceX lines up back-to-back Starlink launches from Florida as orbit crowding comes into focus
Next Story

SpaceX lines up back-to-back Starlink launches from Florida as orbit crowding comes into focus

Go toTop